Clinical Trial Update: A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers [Phase 2]

View source ↗

Summary

Phase II trial evaluating debulking surgery with HIPEC followed by intraperitoneal chemotherapy for recurrent ovarian, primary peritoneal, and fallopian tube ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Columbia University | Conditions: Recurrent Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: TERMINATED | Results posted: 2015-03-03